公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2020 | Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma | Chung C.-J.; Bao B.-Y.; Lin Y.-C.; Huang Y.-L.; Shiue H.-S.; Ao P.-L.; YEONG-SHIAU PU ; CHAO-YUAN HUANG ; Hsueh Y.-M. | Scientific Reports | 10 | 7 | |
2011 | Polymorphisms inside MicroRNAs and MicroRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy | Bao B.-Y.; Pao J.-B.; Huang C.-N.; YEONG-SHIAU PU ; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Chen L.-M.; Hsieh C.-J.; Huang S.-P. | Clinical Cancer Research | 64 | 56 | |
2016 | Prognostic relevance of methylenetetrahydrofolate reductase polymorphisms for prostate cancer | Lin V.C.; Lu T.-L.; Yin H.-L.; Yang S.-F.; Lee Y.-C.; Liu C.-C.; CHAO-YUAN HUANG ; Yu C.-C.; Chang T.-Y.; Huang S.-P.; Bao B.-Y. | International Journal of Molecular Sciences | 7 | 4 | |
2013 | Prognostic significance of cyclin d1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy | Yu C.-C.; Lin V.C.; CHAO-YUAN HUANG ; Liu C.-C.; Wang J.-S.; Wu T.T.; YEONG-SHIAU PU ; Huang C.-H.; Huang C.-N.; Huang S.-P.; Bao B.-Y. | Annals of Surgical Oncology | 17 | 15 | |
2015 | Prognostic significance of genetic polymorphisms in disease progression and survival in prostate cancer after androgen deprivation therapy | Huang T.-Y.; Chien T.-M.; Liu C.-C.; Lee H.-Y.; Yu C.-C.; CHAO-YUAN HUANG ; Chang C.-F.; Huang C.-H.; Wu W.-J.; Bao B.-Y.; Huang S.-P. | Urological Science | 2 | 0 | |
2012 | Prognostic significance of genetic polymorphisms on prostate-specific antigen recurrence after a radical prostatectomy | Tsai Y.-F.; Bao B.-Y.; Liu C.-C.; Huang C.-N.; Yu C.-C.; Wu T.T.; CHAO-YUAN HUANG ; YEONG-SHIAU PU ; Chang C.-F.; Huang C.-H.; Wu W.-J.; Huang S.-P. | Urological Science | 0 | 0 | |
2019 | Prognostic value of CD1B in localised prostate cancer | Lee C.-H.; Chen L.-C.; Yu C.-C.; Lin W.-H.; Lin V.C.; CHAO-YUAN HUANG ; Lu T.-L.; Huang S.-P.; Bao B.-Y. | International Journal of Environmental Research and Public Health | 14 | 11 | |
2016 | Prognostic value of prostaglandin-endoperoxide synthase 2 polymorphisms in prostate cancer recurrence after radical prostatectomy | Lee C.-H.; Pao J.-B.; Lu T.-L.; Lee H.-Z.; Lee Y.-C.; Liu C.-C.; CHAO-YUAN HUANG ; Lin V.C.; Yu C.-C.; Yin H.-L.; Huang S.-P.; Bao B.-Y. | International Journal of Medical Sciences | 5 | 2 | |
2012 | Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy | Bao B.-Y.; Pao J.-B.; Huang C.-N.; YEONG-SHIAU PU ; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Chen L.-M.; Ting W.-C.; Hsieh C.-J.; Huang S.-P. | International Journal of Cancer | 21 | 19 | |
2012 | Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy | Huang S.-P.; Bao B.-Y.; Wu M.-T.; Choueiri T.K.; Goggins W.B.; Liu C.-C.; CHAO-YUAN HUANG ; YEONG-SHIAU PU ; Yu C.-C.; Wu T.T.; Huang C.-N.; Huang C.-H.; Wu W.-J. | Aging Male | 19 | 19 | |
2013 | Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer | Pao J.-B.; Yang Y.-P.; Huang C.-N.; Huang S.-P.; Hour T.-C.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; CHAO-YUAN HUANG ; Bao B.-Y. | World Journal of Urology | 11 | 10 | |
2017 | Vitamin D receptor-binding site variants affect prostate cancer progression | Lin V.C.; Huang S.-P.; Ting H.-J.; Ma W.-L.; Yu C.-C.; CHAO-YUAN HUANG ; Yin H.-L.; Huang T.-Y.; Lee C.-H.; Chang T.-Y.; Lu T.-L.; Bao B.-Y. | Oncotarget | 8 | 8 |